scholarly journals Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group

Haematologica ◽  
2018 ◽  
Vol 104 (1) ◽  
pp. 120-127 ◽  
Author(s):  
Naghmeh Niktoreh ◽  
Beate Lerius ◽  
Martin Zimmermann ◽  
Bernd Gruhn ◽  
Gabriele Escherich ◽  
...  
2021 ◽  
Vol 9 ◽  
pp. 2050313X2110155
Author(s):  
Sachio Fujita ◽  
Ryosuke Matsuno ◽  
Naoko Kawabata ◽  
Yumiko Sugishita ◽  
Ryota Kaneko ◽  
...  

Limited salvage chemotherapies are available for relapsed/refractory acute myeloid leukemia. Herein, we described successful reinduction chemotherapy, involving a combination of clofarabine, cyclophosphamide, and etoposide, in a 12-year-old male with relapsed acute myeloid leukemia prior to allogeneic bone marrow transplantation from his father. Although treatment with a combination of fludarabine, cytarabine, granulocyte colony-stimulating factor, idarubicin, and gemtuzumab ozogamicin had no positive effects, the aforementioned clofarabine-based chemotherapy induced complete remission and allowed the transplantation to go ahead. The abovementioned regimen may be useful for induction chemotherapy prior to hematopoietic stem cell transplantation for refractory/relapsed acute myeloid leukemia.


2018 ◽  
Vol 40 (2) ◽  
pp. 163-168 ◽  
Author(s):  
Anthony Pak-Yin Liu ◽  
Alex Wing-Kwan Leung ◽  
Daniel Ka-Leung Cheuk ◽  
Vincent Lee ◽  
Shau-Yin Ha

2015 ◽  
Vol 56 (8) ◽  
pp. 2326-2330 ◽  
Author(s):  
Sylvain P. Chantepie ◽  
Emilie Reboursiere ◽  
Jean-Baptiste Mear ◽  
Anne-Claire Gac ◽  
Veronique Salaun ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document